Literature DB >> 19477674

[Partial uterine wall necrosis following Cho hemostatic sutures for the treatment of postpartum hemorrhage].

L Reyftmann1, A Nguyen, V Ristic, C Rouleau, N Mazet, H Dechaud.   

Abstract

A 38-year-old woman, gravida 2, para 2, underwent caesarean section at 41 weeks' gestation and suffered postpartum hemorrhage due to uterine atony. Four Cho sutures were used to control hemorrhage. A systematic postpartum hysteroscopy showed a heterogenous whitish area of the fundus and MRI advocated placental retention. However, hysteroscopically guided biopsies confirmed the diagnosis of partial uterine necrosis. We emphasize the need to undergo postoperative follow-up to confirm uterine wall integrity after placement of compression sutures in order to document the complications of this procedure, which remain under evaluated.

Entities:  

Mesh:

Year:  2009        PMID: 19477674     DOI: 10.1016/j.gyobfe.2008.09.025

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  4 in total

1.  Disseminated Intravascular Coagulation leading to Fetal Death in Utero and Uterine Infarction.

Authors:  Yin Peng Goh; Kenneth K Lau
Journal:  J Obstet Gynaecol India       Date:  2013-09-06

2.  Uterine necrosis following a combination of uterine compression sutures and vascular ligation during a postpartum hemorrhage: A case report.

Authors:  Saad Benkirane; Hanane Saadi; Badr Serji; Ahmed Mimouni
Journal:  Int J Surg Case Rep       Date:  2017-07-10

3.  [Partial parietal uterine necrosis after hemostatic padding during a postpartum hemorrhage].

Authors:  Fatima Zohra Fdili Alaoui; Sofia Jayi; Hakima Bouguern; Moulayabdilah Melhouf; Hinde El Fatemi; Afaf Amarti
Journal:  Pan Afr Med J       Date:  2013-05-25

4.  'Nausicaa' compression suture: a simple and effective alternative to hysterectomy in placenta accreta spectrum and other causes of severe postpartum haemorrhage.

Authors:  J-C Shih; K-L Liu; J Kang; J-H Yang; M-W Lin; C-U Yu
Journal:  BJOG       Date:  2018-08-20       Impact factor: 6.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.